Vermont Saw Rise in Cannabis-Related ER Visits

State health data reflects an uptick in hospital visits linked to cannabinoid hyperemesis syndrome since 2016.

Updated on Sept. 25, 2026 in Substance Abuse

Vermont Saw Rise in Cannabis-Related ER Visits

Live Poll

Should states reconsider recreational marijuana legalization due to rising cannabis-related health illnesses?

Vermont emergency departments experienced a rise in hospital visits for cannabis-related poisoning and cannabinoid hyperemesis syndrome between 2016 and 2022. The condition, characterized by severe cycles of nausea and stomach pain, has seen increasing case counts over the last decade.

Why it matters

The rise in these emergency visits has been attributed to cannabis products currently sold containing significantly higher concentrations of THC compared to previous decades. Because no standard medical test exists to diagnose the syndrome, it remains a challenge for healthcare providers to identify and treat effectively.

Official health records confirm a multi-year rise in hospital admissions for cannabinoid hyperemesis syndrome between 2016 and 2022. There is currently no standard medical test available to confirm a diagnosis of the condition.

The players

Centers for Disease Control and Prevention

The national public health agency reported an overall increase in cannabinoid hyperemesis syndrome cases across the country over the last decade.

The details

Patients suffering from cannabinoid hyperemesis syndrome endure severe cycles of vomiting, nausea, and intense stomach pain. Health officials note that the lack of a standardized diagnostic test complicates the ability of medical staff to identify the condition in emergency settings.

Timeline

  1. Cannabis product THC concentrations have risen since the 1970s.

  2. Cannabis poisoning ER visits rose between 2016 and 2022.

  3. Vermont emergency room visits for CHS peaked between 2017 and 2018.

Health Landscape

This regional trend follows a pattern set by the Centers for Disease Control and Prevention's national trend reporting on the condition. The findings highlight the broader evolution of medical challenges posed by modern, high-potency cannabis products.

Residents should be aware that persistent nausea and stomach pain may be linked to cannabis use given the higher THC potency in modern products. Patients experiencing these symptoms should seek clinical evaluation, as the lack of a diagnostic test makes professional medical assessment necessary.

The takeaway

Patients who use cannabis products frequently should discuss their symptoms and usage habits openly with healthcare providers. Since the condition is diagnosed through clinical observation rather than a specific lab test, clear communication is essential for accurate care.

Further reading

Learn more about local health trends at the Substance Abuse section.

Source note: This article includes information reported by Wcax.

Live Poll

Should states reconsider recreational marijuana legalization due to rising cannabis-related health illnesses?